Stay updated on NEBULAMB Clinical Trial

Sign up to get notified when there's something new on the NEBULAMB Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NEBULAMB Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    A site-wide NIH notice about updates to “Artificial Intelligence” terminology was removed from the top of the page.
    Difference
    1%
    Check dated 2026-11-07T14:39:54.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T15:38:31.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s transition terminology, including the use of “Super Intelligence” alongside “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-24T16:44:28.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2. The page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T16:32:01.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T16:51:37.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page instead of the study record, with a Home button and standard footer. This indicates an access restriction rather than a substantive update to the study content.
    Difference
    16%
    Check dated 2026-09-19T22:18:39.000Z thumbnail image

Stay in the know with updates to NEBULAMB Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NEBULAMB Clinical Trial page.